Expand ATHA Menu
ATHA MENU

ATHA Stock Posts


Unusual Option Volume

ATHA Athira Pharma0.63-2.20 (-77.7%)

Athira Pharma trades 3,512 contracts. The company has the following event: 17th Clinical Trials on Alzheimer's Disease (CTAD) conference between Oct 29, 2024 and Nov 1, 2024. News: Athira Pharma Announces Topline Results from Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton for Mild-to-Moderate Alzheimer's Disease
View Details...
Unusual Option Volume

ATHA Athira Pharma2.86-0.23 (-7.4%)

Athira Pharma trades 2,318 contracts. The company has the following event: 17th Clinical Trials on Alzheimer's Disease (CTAD) conference between Oct 29, 2024 and Nov 1, 2024. News: Athira Pharma Announces Topline Results from Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton for Mild-to-Moderate Alzheimer's Disease
View Details...
Unusual Option Volume

ATHA Athira Pharma3.48+0.55 (+18.8%)

Athira Pharma trades 2,227 contracts. The company has the following event: 17th Clinical Trials on Alzheimer's Disease (CTAD) conference between Oct 29, 2024 and Nov 1, 2024.
View Details...
Unusual Option Volume

ATHA Athira Pharma2.60-5.85 (-69.2%)

Athira Pharma trades 1,735 contracts. News: Athira Pharma Announces Topline Results from ACT-AD Phase 2 Proof of Concept Study of Fosgonimeton in Mild-to-Moderate Alzheimer's Disease
View Details...
ATHA #AthiraPharma stock declines -65.7% in premarket,

Premarket Decliner

ATHA Athira Pharma8.45-0.15-1.7%

Premarket:2.90-5.55 (-65.7%)

Athira Pharma Announces Topline Results from ACT-AD Phase 2 Proof of Concept Study of Fosgonimeton in Mild-to-Moderate Alzheimer's Disease

Globe NewswireWed, 22-Jun 7:00 AM
Unusual Option Volume

ATHA Athira Pharma9.36+0.19 (+2.1%)

Athira Pharma trades 3,638 contracts.
View Details...
Load Earlier Posts
Market Data Delayed 15 Minutes